Neuromuscular Ultrasound as the Sole Diagnostic Test for Carpal Tunnel Syndrome in Hunter Syndrome

2021 ◽  
Author(s):  
Benjamin D. Smart ◽  
Michael S. Cartwright
Keyword(s):  
Carpal Tunnel Syndrome ◽  
Diagnostic Test ◽  
Carpal Tunnel ◽  
Hunter Syndrome ◽  
Tunnel Syndrome

Ultrasonography for Diagnosing Carpal Tunnel Syndrome: A Meta-Analysis of Diagnostic Test Accuracy

2012 ◽  
Vol 38 (7) ◽  
pp. 1121-1128 ◽  
Author(s):  
Ta-Wei Tai ◽  
Cheng-Yi Wu ◽  
Fong-Chin Su ◽  
Tai-Chang Chern ◽  
I-Ming Jou
Keyword(s):  
Carpal Tunnel Syndrome ◽  
Diagnostic Test ◽  
Carpal Tunnel ◽  
Meta Analysis ◽  
Diagnostic Test Accuracy ◽  
Test Accuracy ◽  
Tunnel Syndrome

scholarly journals Hunter Syndrome (Mucopolysaccharidosis II) – The Signs and Symptoms a Neurologist Needs to Know

2015 ◽  
Vol 10 (01) ◽  
pp. 90 ◽  
Author(s):  
Hernan Amartino ◽  
Keyword(s):  
Spinal Cord ◽  
Carpal Tunnel Syndrome ◽  
Spinal Cord Compression ◽  
Carpal Tunnel ◽  
Specific Treatment ◽  
Brain Magnetic Resonance Imaging ◽  
Hunter Syndrome ◽  
Cord Compression ◽  
Mucopolysaccharidosis Ii ◽  
Tunnel Syndrome

Hunter syndrome (mucopolysaccharidosis II) is a rare X-linked lysosomal storage disease caused by deficiency of the enzyme iduronate-2-sulfatase. The condition is one of a group of disorders, the mucopolysaccharidoses, which all result in accumulation of glycosaminoglycans. Hunter syndrome is a chronic progressive disorder whose clinical manifestations vary widely in severity and involve multiple organs and tissues. In addition to developing somatic symptoms, patients having the neuronopathic form of the disease also display developmental delay and cognitive impairment in early childhood that progressively worsens and that is severely life-limiting. Patients are at risk of developing secondary neurological manifestations, including hydrocephalus, vision and hearing loss, carpal tunnel syndrome and spinal cord compression. Common findings from brain magnetic resonance imaging (MRI) scans and at autopsy include neurodegenerative changes in white matter, the corpus callosum and basal ganglia; enlargement of periventricular spaces; ventriculomegaly; closed cephaloceles; and tissue atrophy. Though at present there is no specific treatment for the neurodegenerative aspects of the disease, hydrocephalus, carpal tunnel syndrome and spinal cord compression can be managed surgically. Patients who have Hunter syndrome should receive coordinated care from a multidisciplinary team: in light of the extensive neurological symptoms of the disease, neurologists play an important role in the diagnosis and management of this condition.

Ultrasound findings of carpal tunnel syndrome in a hunter syndrome patient

2016 ◽  
Vol 53 (4) ◽  
pp. 661-662
Author(s):  
Daniele Coraci ◽  
Chiara Cambise ◽  
Filippo Maria Del Tedesco ◽  
Valter Santilli ◽  
Luca Padua
Keyword(s):  
Carpal Tunnel Syndrome ◽  
Carpal Tunnel ◽  
Hunter Syndrome ◽  
Syndrome Patient ◽  
Ultrasound Findings ◽  
Tunnel Syndrome

A Diagnostic Test for Carpal Tunnel Syndrome Using Ultrasound

1993 ◽  
Vol 18 (3) ◽  
pp. 408-408
Author(s):  
P. J. A. Molitor
Keyword(s):  
Carpal Tunnel Syndrome ◽  
Diagnostic Test ◽  
Carpal Tunnel ◽  
Therapeutic Ultrasound ◽  
Tunnel Syndrome

The paper describes the details of an ultrasound test for carpal tunnel syndrome and compares the results of this with EMG studies in a series of 19 patients. The equipment used was a standard therapeutic ultrasound unit and the tests were performed by a physiotherapist. The results were encouraging, with a 90% correlation with EMG results.

Sign in / Sign up

Export Citation Format

Share Document